Eric Neri

Eric Neri

Auto-generated profile, based on publicly available information

Eric Neri

Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, United States

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2019 in JMIR Mental Health
Verified
Journal Article
Open access
JTJenna Tregarthen
Jenna Tregarthen
JKJane Paik Kim
Jane Paik Kim
SSShiri Sadeh-Sharvit
Shiri Sadeh-Sharvit
ENEric Neri
Eric Neri
HWHannah Welch
Hannah Welch
JLJames Lock
James Lock
Background: Eating disorders severely impact psychological, physical, and social functioning, and yet, the majority of individuals with eating disorders do not receive treatment. Mobile health apps have the potential to decrease access barriers to care and reach individuals who have been underserved by traditional treatment modalities. Objective: The objective of this study was to evaluate the effectiveness of a tailored, fully automated self-help version of Recovery Record, an app developed for eating disorders management. We examined differences in eastin disorder symptom change in app users that were randomized to receive either a standard, cognitive behavioral therapy–based version of the app or a tailored version that included algorithmically determined clinical content aligned with baseline and evolving user eating disorder symptom profiles. Methods: Participants were people with eating disorder symptoms who did not have access to traditional treatment options and were recruited via the open-access Recovery Record app to participate in this randomized controlled trial. We examined both continuous and categorical clinical improvement outcomes (measured with the self-report Eating Disorder Examination Questionnaire [EDE-Q]) in both intervention groups. Results: Between December 2016 and August 2018, 3294 Recovery Record app users were recruited into the study, out of which 959 were considered engaged, completed follow-up assessments, and were included in the analyses. Both study groups achieved significant overall outcome improvement, with 61.6% (180/292) of the tailored group and 55.4% (158/285) of the standard group achieving a clinically meaningful change in the EDE-Q, on average. There were no statistically significant differences between randomized groups for continuous outcomes, but a pattern of improvement being greater in the tailored group was evident. The rate of remission on the EDE-Q at 8 weeks was significantly greater in the group receiving the tailored version (d=0.22; P≤.001). Conclusions: This is the first report to compare the relative efficacy of two versions of a mobile app for eating disorders. The data suggest that underserved individuals with eating disorder symptoms may benefit clinically from a self-help app and that personalizing app content to specific clinical presentations may be more effective in promoting symptomatic remission on the EDE-Q than content that offers a generic approach. Trial Registration: ClinicalTrials.gov NCT02503098; https://clinicaltrials.gov/ct2/show/NCT02503098.

4 November 2022 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
CMCarmen McLean
Carmen McLean
CDC Adrian Davis
C Adrian Davis
MMMadeleine Miller
Madeleine Miller
JRJosef Ruzek
Josef Ruzek
ENEric Neri
Eric Neri
Background: Barriers to accessing in-person care can prevent veterans with posttraumatic stress disorder (PTSD) from receiving trauma-focused treatments such as exposure therapy. Mobile apps may help to address unmet need for services by offering tools for users to self-manage PTSD symptoms. Renew is a mobile mental health app that focuses on exposure therapy and incorporates a social support function designed to promote user engagement. Objective: We examined the preliminary efficacy of Renew with and without support from a research staff member compared with waitlist among 93 veterans with clinically significant PTSD symptoms. We also examined the impact of study staff support on participant engagement with the app. Methods: In a pilot randomized controlled trial, we compared Renew with and without support from a research staff member (active use condition) with waitlist (delayed use condition) over 6 weeks. Participants were recruited through online advertisements. The Posttraumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) was used to measure PTSD symptoms at pre, post, and 6-week follow-up. Usage data were collected to assess engagement with Renew. Results: Results indicated a small effect size (d=–0.39) favoring those in the active use conditions relative to the delayed use condition, but the between-group difference was not significant (P=.29). There were no differences on indices of app engagement between the 2 active use conditions. Exploratory analyses found that the number of support persons users added to the app, but not the number of support messages received, was positively correlated with app engagement. Conclusions: Findings suggest Renew may hold promise as a self-management tool to reduce PTSD symptoms in veterans. Involving friends and family in mobile mental health apps may help bolster engagement with no additional cost to public health systems. Trial Registration: ClinicalTrials.gov NCT04155736; https://clinicaltrials.gov/ct2/show/NCT04155736

1 December 2018 in Journal of Palliative Medicine
Verified
Journal Article
Open access
MAMuthuraman Alagappan
Muthuraman Alagappan
MRMichael Richardson
Michael Richardson
MSMatthew K. Schoen
Matthew K. Schoen
LMLori Muffly
Lori Muffly
KTKathryn Tierney
Kathryn Tierney
VPVyjeyanthi S. Periyakoil
Vyjeyanthi S. Periyakoil
Background: Little is known about the extent of alignment between hematopoietic stem cell transplant (HSCT) patients and their healthcare proxies with respect to advance care planning (ACP). Aim: To determine if a structured three-step process using the letter advance directive (LAD) could (1) allow for the differences in opinion between patient–proxy dyads to surface and (2) help bridge preexisting discordance about specific treatment choices. Design: Blinded to each other, the HSCT patient (LAD-1) and proxy (LAD-2) each completed the LAD (step 1). They unmasked, compared LAD-1 and LAD-2, and discussed their choices (step 2). They completed a final letter directive (LAD-3) by consensus (step 3). Settings/Participants: Convenience sample of eighty dyads (patient and proxy) at a regional HSCT referral center. Results: The mean patient–proxy concordance was 72.9% for the 12 questions in the LAD. Wanting to be pain free at the end of life was the statement with the most amount of agreement (88.75% in LAD-1, 91.25% in LAD-2, and 90% in LAD-3). Patient–proxy dyads had notable discordance related to specific treatments. The highest discordance was related to ventilator support (46.3% of patients refused it, while 58.8% of proxies refused on behalf of the patient). Overall, proxies were more likely than patients to opt in for dialyses and hospice care but more likely to opt out for cardiac resuscitation and sedation to palliate refractory symptoms. On open discussion, patient–proxy discordance mostly resolved in favor of the patient. Conclusions: The ACP process should allow for patient–proxy differences to surface, facilitate a discussion about the granular details with the goal of reaching consensus. Our three-step approach using the LAD is an effective way to identify areas of patient–proxy concordance and discordance about specific treatment preferences. A structured patient–proxy discussion using the LAD helped reconcile discordance and most often in favor of a patient's original wishes.

10 March 2026 in JMIR Preprints
Verified
Preprint
Open access
VPVyjeyanthi Periyakoil
Vyjeyanthi Periyakoil
ENEric Neri
Eric Neri
HKHelena Kraemer
Helena Kraemer
BACKGROUND Women in medicine report frequently encountering microaggressions that contribute to burnout, diminished belonging, and attrition, yet brief, scalable trainings to improve recognition skills are understudied. OBJECTIVE This study reports the impact of a 90-minute, virtual, video-based course impact on health professionals’ ability to discern microaggressions from non-microaggressive encounters using a performance-based assessment. METHODS 304 health professionals across completed a pretest with four paired microaggression (MA) and non-microaggression (NMA) videos, a virtual 90-minute course (“Microaggressions have macro-consequences”) grounded in Kolb’s experiential learning cycle, and a posttest with four new MA–NMA pairs. After each video, participants rated microaggressive content on a 7-point Likert scale, which was used to calculate a Microaggression Discernment Score. The primary outcome was change in this score from pre- to posttest. Exploratory quantitative recursive partitioning examined associations between change scores, baseline discernment, and demographics. RESULTS Participants included physicians (31.9%), nurses (30.3%), and other health professionals (37.9%), most of whom identified as female (62.7%). Overall, 66.1% demonstrated improved discernment, 13.5% showed no change, and 20.4% regressed; the median percent change in correct identification was 12.5% (interquartile range 0.0–33.3; range −83.3 to 87.5). Baseline discernment score was the primary predictor of improvement: 80.9% of participants with intermediate pretest scores improved, compared with 41.0% with low and 41.4% with high pretest scores. CONCLUSIONS A virtual, scenario-based, video training was associated with meaningful improvements in health professionals’ ability to discern microaggressions from non-microaggressive encounters, particularly among those with intermediate baseline skills. Performance-based recognition measures can help institutions target and track microaggression education as part of broader efforts to foster psychologically safe, respectful learning and practice environments for women in medicine.

3 March 2023 in PsyArXiv
Verified
Preprint
Open access
JZJin-Xiao Zhang
Jin-Xiao Zhang
AKAllison Kurian
Allison Kurian
BJBooil Jo
Booil Jo
BNBita Nouriani
Bita Nouriani
ENEric Neri
Eric Neri
David SpiegelDavid Spiegel
David Spiegel
Background: There has been steadily increasing use of bilateral mastectomy (BMX) in the treatment of primary breast cancer (BC). In this study, we utilized functional magnetic resonance imaging (fMRI) to examine the influence of emotion regulation on the decision of newly diagnosed BC patients to choose BMX rather than non-BMX treatments. Methods: We recruited 123 women with unilateral BC, 61 of whom received BMX and 62 of whom received non-BMX treatments, and 39 healthy controls. While participants were in the fMRI scanner, we showed them BC-related and non-BC negative images. In one condition they were instructed to watch the images naturally. In another they were instructed to regulate their negative emotion. We compared the fMRI signal during these conditions throughout the brain.Results: With non-BC negative images as the baseline, BC patients showed greater self-reported reactivity and neural reactivity to BC-related images in brain regions associated with self-reflection than did controls. Among the BC patients, the BMX group showed weaker activation in prefrontal emotion regulation brain regions during emotion regulation than did the non-BMX group.Conclusions: BC patients are understandably emotionally hyper-reactive to BC-related stimuli and those who ultimately received BMX experience more difficulty in regulating BC-related negative emotion than non-BMX BC patients. These findings offer neuropsychological evidence that difficulty in managing anxiety related to the possibility of cancer recurrence is a factor in surgical treatment decision-making and may be an intervention target with the goal of strengthening the management of cancer-related anxiety by non-surgical means.

10 June 2019 in JMIR Preprints
Verified
Preprint
Open access
JTJenna Tregarthen
Jenna Tregarthen
JKJane Paik Kim
Jane Paik Kim
SSShiri Sadeh-Sharvit
Shiri Sadeh-Sharvit
ENEric Neri
Eric Neri
HWHannah Welch
Hannah Welch
JLJames Lock
James Lock
BACKGROUND Eating disorders severely impact psychological, physical, and social functioning, and yet, the majority of individuals with eating disorders do not receive treatment. Mobile health apps have the potential to decrease access barriers to care and reach individuals who have been underserved by traditional treatment modalities. OBJECTIVE The objective of this study was to evaluate the effectiveness of a tailored, fully automated self-help version of Recovery Record, an app developed for eating disorders management. We examined differences in eastin disorder symptom change in app users that were randomized to receive either a standard, cognitive behavioral therapy–based version of the app or a tailored version that included algorithmically determined clinical content aligned with baseline and evolving user eating disorder symptom profiles. METHODS Participants were people with eating disorder symptoms who did not have access to traditional treatment options and were recruited via the open-access Recovery Record app to participate in this randomized controlled trial. We examined both continuous and categorical clinical improvement outcomes (measured with the self-report Eating Disorder Examination Questionnaire [EDE-Q]) in both intervention groups. RESULTS Between December 2016 and August 2018, 3294 Recovery Record app users were recruited into the study, out of which 959 were considered engaged, completed follow-up assessments, and were included in the analyses. Both study groups achieved significant overall outcome improvement, with 61.6% (180/292) of the tailored group and 55.4% (158/285) of the standard group achieving a clinically meaningful change in the EDE-Q, on average. There were no statistically significant differences between randomized groups for continuous outcomes, but a pattern of improvement being greater in the tailored group was evident. The rate of remission on the EDE-Q at 8 weeks was significantly greater in the group receiving the tailored version (d=0.22; P≤.001). CONCLUSIONS This is the first report to compare the relative efficacy of two versions of a mobile app for eating disorders. The data suggest that underserved individuals with eating disorder symptoms may benefit clinically from a self-help app and that personalizing app content to specific clinical presentations may be more effective in promoting symptomatic remission on the EDE-Q than content that offers a generic approach. CLINICALTRIAL ClinicalTrials.gov NCT02503098; https://clinicaltrials.gov/ct2/show/NCT02503098.